PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT)

Historical Holders from Q1 2014 to Q1 2025

Symbol
PTCT on Nasdaq
CUSIP
69366J200
Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
77.1M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
77.7M
Holdings value
$3.51B
% of all portfolios
0.003%
Grand Portfolio weight change
0%
Number of holders
237
Number of buys
124
Number of sells
-90
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 8.27% $325M 6.38M Armistice Capital, LLC Dec 31, 2024
BlackRock, Inc. 8% $320M 6.27M BlackRock, Inc. Mar 31, 2025
WELLINGTON MANAGEMENT GROUP LLP 6.2% $244M 4.79M Wellington Management Group LLP Dec 31, 2024
Camber Capital Management LP 4.15% $163M 3.2M Camber Capital Management LP Dec 31, 2024

Institutional Holders of PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 556K $28.3M -$4.4M $50.96 22
2024 Q4 77.7M $3.51B -$16.1M $45.14 237
2024 Q3 78.8M $2.93B -$39.1M $37.10 200
2024 Q2 79.8M $2.44B -$156M $30.58 197
2024 Q1 85.1M $2.47B -$415K $29.09 179
2023 Q4 83.4M $2.3B +$48.7M $27.56 168
2023 Q3 81.1M $1.82B -$59.6M $22.41 173
2023 Q2 80.4M $3.27B +$72.1M $40.67 199
2023 Q1 78.4M $3.8B +$91M $48.44 196
2022 Q4 75.9M $2.9B +$9.59M $38.17 192
2022 Q3 74.3M $3.73B +$99.2M $50.20 193
2022 Q2 73.8M $2.96B +$12.6M $40.06 169
2022 Q1 73.5M $2.74B -$36.8M $37.31 168
2021 Q4 75.1M $2.99B +$33.2M $39.83 165
2021 Q3 74.2M $2.76B +$31.3M $37.21 175
2021 Q2 73.8M $3.12B +$4.07M $42.27 171
2021 Q1 73.8M $3.5B +$45.9M $47.35 197
2020 Q4 72.8M $4.44B +$102M $61.03 204
2020 Q3 70.9M $3.32B +$115M $46.75 185
2020 Q2 68M $3.43B +$247M $50.74 192
2020 Q1 64.2M $2.86B +$127M $44.61 193
2019 Q4 61M $2.93B +$23.6M $48.03 201
2019 Q3 61.8M $2.09B +$115M $33.82 177
2019 Q2 58.3M $2.62B +$35.4M $45.00 169
2019 Q1 58.6M $2.21B +$365M $37.64 168
2018 Q4 48.8M $1.67B +$32.7M $34.32 158
2018 Q3 46M $2.16B +$195M $47.00 174
2018 Q2 42.7M $1.44B +$13.2M $33.73 162
2018 Q1 42.6M $1.15B +$141M $27.06 144
2017 Q4 37.5M $626M +$15.9M $16.68 115
2017 Q3 35.7M $715M +$44.6M $20.01 125
2017 Q2 33.1M $606M +$68M $18.33 109
2017 Q1 31.5M $310M +$57.2M $9.84 111
2016 Q4 28.6M $312M -$24.4M $10.91 114
2016 Q3 29.2M $409M +$31.6M $14.01 110
2016 Q2 28.6M $202M -$3.58M $7.02 113
2016 Q1 28.3M $182M -$209M $6.44 106
2015 Q4 36.3M $1.18B +$118M $32.40 141
2015 Q3 32.6M $870M -$27.5M $26.70 150
2015 Q2 32M $1.54B +$90.3M $48.13 147
2015 Q1 30.2M $1.84B +$209M $60.85 157
2014 Q4 27.1M $1.41B +$218M $51.77 129
2014 Q3 22.8M $1B +$106M $44.01 98
2014 Q2 22.9M $599M +$25.1M $26.14 82
2014 Q1 23M $600M +$234M $26.14 63